Cite
MLA Citation
Maria-Victoria Mateos et al.. “Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial.” Lancet, vol. 6, no. 9, 2019, pp. e459–e469. http://access.bl.uk/ark:/81055/vdc_100091258589.0x000009